List of Tables
Table 1. In Vitro ADME-Tox Market Trends
Table 2. In Vitro ADME-Tox Market Drivers & Opportunity
Table 3. In Vitro ADME-Tox Market Challenges
Table 4. In Vitro ADME-Tox Market Restraints
Table 5. Global In Vitro ADME-Tox Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global In Vitro ADME-Tox Revenue Market Share by Company (2019-2024)
Table 7. Key Companies In Vitro ADME-Tox Manufacturing Base Distribution and Headquarters
Table 8. Key Companies In Vitro ADME-Tox Product Type
Table 9. Key Companies Time to Begin Mass Production of In Vitro ADME-Tox
Table 10. Global In Vitro ADME-Tox Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro ADME-Tox as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global In Vitro ADME-Tox Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global In Vitro ADME-Tox Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global In Vitro ADME-Tox Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global In Vitro ADME-Tox Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global In Vitro ADME-Tox Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global In Vitro ADME-Tox Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global In Vitro ADME-Tox Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global In Vitro ADME-Tox Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global In Vitro ADME-Tox Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global In Vitro ADME-Tox Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global In Vitro ADME-Tox Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global In Vitro ADME-Tox Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global In Vitro ADME-Tox Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global In Vitro ADME-Tox Sales Value by Region (2019-2024) & (%)
Table 27. Global In Vitro ADME-Tox Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions In Vitro ADME-Tox Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions In Vitro ADME-Tox Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions In Vitro ADME-Tox Sales Value, (2025-2030) & (US$ Million)
Table 31. Charles River Basic Information List
Table 32. Charles River Description and Business Overview
Table 33. Charles River In Vitro ADME-Tox Products, Services and Solutions
Table 34. Revenue (US$ Million) in In Vitro ADME-Tox Business of Charles River (2019-2024)
Table 35. Charles River Recent Developments
Table 36. Labcorp Basic Information List
Table 37. Labcorp Description and Business Overview
Table 38. Labcorp In Vitro ADME-Tox Products, Services and Solutions
Table 39. Revenue (US$ Million) in In Vitro ADME-Tox Business of Labcorp (2019-2024)
Table 40. Labcorp Recent Developments
Table 41. Envigo Basic Information List
Table 42. Envigo Description and Business Overview
Table 43. Envigo In Vitro ADME-Tox Products, Services and Solutions
Table 44. Revenue (US$ Million) in In Vitro ADME-Tox Business of Envigo (2019-2024)
Table 45. Envigo Recent Developments
Table 46. Curia Basic Information List
Table 47. Curia Description and Business Overview
Table 48. Curia In Vitro ADME-Tox Products, Services and Solutions
Table 49. Revenue (US$ Million) in In Vitro ADME-Tox Business of Curia (2019-2024)
Table 50. Curia Recent Developments
Table 51. Evotec Basic Information List
Table 52. Evotec Description and Business Overview
Table 53. Evotec In Vitro ADME-Tox Products, Services and Solutions
Table 54. Revenue (US$ Million) in In Vitro ADME-Tox Business of Evotec (2019-2024)
Table 55. Evotec Recent Developments
Table 56. Bioduro-Sundia Basic Information List
Table 57. Bioduro-Sundia Description and Business Overview
Table 58. Bioduro-Sundia In Vitro ADME-Tox Products, Services and Solutions
Table 59. Revenue (US$ Million) in In Vitro ADME-Tox Business of Bioduro-Sundia (2019-2024)
Table 60. Bioduro-Sundia Recent Developments
Table 61. Lonza Basic Information List
Table 62. Lonza Description and Business Overview
Table 63. Lonza In Vitro ADME-Tox Products, Services and Solutions
Table 64. Revenue (US$ Million) in In Vitro ADME-Tox Business of Lonza (2019-2024)
Table 65. Lonza Recent Developments
Table 66. WuXi AppTec Basic Information List
Table 67. WuXi AppTec Description and Business Overview
Table 68. WuXi AppTec In Vitro ADME-Tox Products, Services and Solutions
Table 69. Revenue (US$ Million) in In Vitro ADME-Tox Business of WuXi AppTec (2019-2024)
Table 70. WuXi AppTec Recent Developments
Table 71. IQVIA Basic Information List
Table 72. IQVIA Description and Business Overview
Table 73. IQVIA In Vitro ADME-Tox Products, Services and Solutions
Table 74. Revenue (US$ Million) in In Vitro ADME-Tox Business of IQVIA (2019-2024)
Table 75. IQVIA Recent Developments
Table 76. Tecan Group Basic Information List
Table 77. Tecan Group Description and Business Overview
Table 78. Tecan Group In Vitro ADME-Tox Products, Services and Solutions
Table 79. Revenue (US$ Million) in In Vitro ADME-Tox Business of Tecan Group (2019-2024)
Table 80. Tecan Group Recent Developments
Table 81. Pharmaron Basic Information List
Table 82. Pharmaron Description and Business Overview
Table 83. Pharmaron In Vitro ADME-Tox Products, Services and Solutions
Table 84. Revenue (US$ Million) in In Vitro ADME-Tox Business of Pharmaron (2019-2024)
Table 85. Pharmaron Recent Developments
Table 86. Shanghai Medicilon Basic Information List
Table 87. Shanghai Medicilon Description and Business Overview
Table 88. Shanghai Medicilon In Vitro ADME-Tox Products, Services and Solutions
Table 89. Revenue (US$ Million) in In Vitro ADME-Tox Business of Shanghai Medicilon (2019-2024)
Table 90. Shanghai Medicilon Recent Developments
Table 91. ChemPartner Basic Information List
Table 92. ChemPartner Description and Business Overview
Table 93. ChemPartner In Vitro ADME-Tox Products, Services and Solutions
Table 94. Revenue (US$ Million) in In Vitro ADME-Tox Business of ChemPartner (2019-2024)
Table 95. ChemPartner Recent Developments
Table 96. Joinn Laboratories Basic Information List
Table 97. Joinn Laboratories Description and Business Overview
Table 98. Joinn Laboratories In Vitro ADME-Tox Products, Services and Solutions
Table 99. Revenue (US$ Million) in In Vitro ADME-Tox Business of Joinn Laboratories (2019-2024)
Table 100. Joinn Laboratories Recent Developments
Table 101. RTI International Basic Information List
Table 102. RTI International Description and Business Overview
Table 103. RTI International In Vitro ADME-Tox Products, Services and Solutions
Table 104. Revenue (US$ Million) in In Vitro ADME-Tox Business of RTI International (2019-2024)
Table 105. RTI International Recent Developments
Table 106. Eurofins Scientific Basic Information List
Table 107. Eurofins Scientific Description and Business Overview
Table 108. Eurofins Scientific In Vitro ADME-Tox Products, Services and Solutions
Table 109. Revenue (US$ Million) in In Vitro ADME-Tox Business of Eurofins Scientific (2019-2024)
Table 110. Eurofins Scientific Recent Developments
Table 111. Aragen Life Sciences Basic Information List
Table 112. Aragen Life Sciences Description and Business Overview
Table 113. Aragen Life Sciences In Vitro ADME-Tox Products, Services and Solutions
Table 114. Revenue (US$ Million) in In Vitro ADME-Tox Business of Aragen Life Sciences (2019-2024)
Table 115. Aragen Life Sciences Recent Developments
Table 116. Sai Life Sciences Basic Information List
Table 117. Sai Life Sciences Description and Business Overview
Table 118. Sai Life Sciences In Vitro ADME-Tox Products, Services and Solutions
Table 119. Revenue (US$ Million) in In Vitro ADME-Tox Business of Sai Life Sciences (2019-2024)
Table 120. Sai Life Sciences Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. In Vitro ADME-Tox Downstream Customers
Table 124. In Vitro ADME-Tox Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. In Vitro ADME-Tox Product Picture
Figure 2. Global In Vitro ADME-Tox Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 4. In Vitro ADME-Tox Report Years Considered
Figure 5. Global In Vitro ADME-Tox Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vitro ADME-Tox Revenue in 2023
Figure 7. In Vitro ADME-Tox Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Small Molecules Picture
Figure 9. Biologics Picture
Figure 10. Global In Vitro ADME-Tox Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global In Vitro ADME-Tox Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Biopharmaceutical Companies
Figure 13. Product Picture of Government and Academic Institutes
Figure 14. Product Picture of Others
Figure 15. Global In Vitro ADME-Tox Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global In Vitro ADME-Tox Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 18. North America In Vitro ADME-Tox Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe In Vitro ADME-Tox Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific In Vitro ADME-Tox Sales Value by Country (%), 2023 VS 2030
Figure 23. South America In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 24. South America In Vitro ADME-Tox Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa In Vitro ADME-Tox Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa In Vitro ADME-Tox Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions In Vitro ADME-Tox Sales Value (%), (2019-2030)
Figure 28. United States In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 30. United States In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 34. China In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 35. China In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 36. China In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 46. India In Vitro ADME-Tox Sales Value, (2019-2030) & (US$ Million)
Figure 47. India In Vitro ADME-Tox Sales Value by Type (%), 2023 VS 2030
Figure 48. India In Vitro ADME-Tox Sales Value by Application (%), 2023 VS 2030
Figure 49. In Vitro ADME-Tox Industrial Chain
Figure 50. In Vitro ADME-Tox Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
